Douglas V. Faller
Affiliations: | Boston University, Boston, MA, United States |
Area:
Cell Biology, Microbiology BiologyGoogle:
"Douglas Faller"Collaborators
Sign in to add collaborator| Walter H. Moos | collaborator | Boston University & School of Medicine (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moos WH, Faller DV, Glavas IP, et al. (2023) Epilepsy: Mitochondrial Connections to the 'Sacred' Disease. Mitochondrion |
| Moos WH, Faller DV, Glavas IP, et al. (2022) Treatment and Prevention of Pathological Mitochondrial Dysfunction in Retinal Degeneration and in Photoreceptor Injury. Biochemical Pharmacology. 115168 |
| Moos WH, Faller DV, Glavas IP, et al. (2021) Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193: 114809 |
| Moos WH, Faller DV, Glavas IP, et al. (2020) Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105 |
| Porcu P, Haverkos B, Brem E, et al. (2019) A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas. Journal of Clinical Oncology. 37: 7551-7551 |
| Porcu P, Haverkos BM, Alpdogan O, et al. (2019) Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study Blood. 134: 465-465 |
| Moos WH, Faller DV, Glavas IP, et al. (2019) Epigenetic treatment of dermatologic disorders Drug Development Research. 80: 702-713 |
| Moos WH, Faller DV, Glavas IP, et al. (2018) A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115 |
| Moos WH, Faller DV, Glavas IP, et al. (2017) Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181 |
| Kodukula K, Faller DV, Harpp DN, et al. (2017) Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Bioresearch Open Access. 6: 123-132 |